Pipeline developments are expected to play a crucial role in Teva’s future. The upcoming Phase 2 top-line results for Anti-TL1A in Q4 2024 and the advancement of Duvakitug’s subcutaneous formulation ...

Duvakitug is an important asset for both Sanofi and Teva. It’s one of a class of drugs that target a protein called TL1A, which is implicated in the inflammation seen in diseases like Crohn’s and ...

It is also the first and only randomized, blinded and placebo-controlled phase 2 study to investigate the impact of TL1A in CD. In the study, patients who met pre-specified inclusion criteria were ...

TL1A, commonly called TNFSF15, belongs to the tumor necrosis factor family. TL1A is expressed in a variety of immune cells, including monocytes, macrophages, dendritic cells, T cells, and others.

One of these, the TL1A pathway, plays a key role in driving inflammation and fibrosis in various autoimmune diseases, making its inhibition a promising strategy for multiple indications, including ...

Spyre’s pipeline includes extended half-life antibodies targeting α4β7, TL1A, and IL-23. For more information, visit Spyre’s website at www.spyre.com.

The Kappa emote is one of the most popular Twitch emotes in existence, but it is kind of an odd one. A lot of people might wonder what does Kappa mean? This one is a bit vaguer than with a lot of ...